Kaoru Asano - Sysmex Director
| SSMXF Stock | USD 20.13 0.00 0.00% |
Director
Mr. Kaoru Asano was serving as Senior Managing Executive Officer, Chief Operating Officer of LS Business Unit, Chief Technology Officer and Director in Sysmex Corporation since April 2018. He joined the Company in August 1987. He previously served as Executive Officer, Senior Executive Officer and Managing Executive Officer in the Company. since 2018.
| Age | 65 |
| Tenure | 6 years |
| Phone | 81 78 265 0500 |
| Web | https://www.sysmex.co.jp |
Sysmex Management Efficiency
The company has return on total asset (ROA) of 0.0955 % which means that it generated a profit of $0.0955 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1315 %, meaning that it generated $0.1315 on every $100 dollars invested by stockholders. Sysmex's management efficiency ratios could be used to measure how well Sysmex manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Maria Rivas | The Cooper Companies, | 57 | |
| William Feehery | West Pharmaceutical Services | 50 | |
| Robert Friel | West Pharmaceutical Services | 65 | |
| Jody Lindell | The Cooper Companies, | 69 | |
| Paolo Pucci | West Pharmaceutical Services | 59 | |
| Kim Duncan | The Cooper Companies, | N/A | |
| Sebastian Frericks | Carl Zeiss Meditec | N/A | |
| Thomas Hofmann | West Pharmaceutical Services | 68 | |
| Mark Buthman | West Pharmaceutical Services | 60 | |
| Gary Petersmeyer | The Cooper Companies, | 73 | |
| Deborah Tanner | West Pharmaceutical Services | 57 | |
| Myla LaiGoldman | West Pharmaceutical Services | 62 | |
| Arthur MD | Alcon AG | 62 | |
| William Kozy | The Cooper Companies, | 69 | |
| Douglas Michels | West Pharmaceutical Services | 63 | |
| Colleen Jay | The Cooper Companies, | 58 | |
| Paula Johnson | West Pharmaceutical Services | 59 | |
| Thomas Barfod | Coloplast A | 53 | |
Management Performance
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0955 |
Sysmex Leadership Team
Elected by the shareholders, the Sysmex's board of directors comprises two types of representatives: Sysmex inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sysmex. The board's role is to monitor Sysmex's management team and ensure that shareholders' interests are well served. Sysmex's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sysmex's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kenji Tachibana, Executive VP of Bus. Strategy Devel., Sr. Executive Officer and Member of the Managing Board | ||
| Tomokazu Yoshida, Executive Officer | ||
| Hisashi Ietsugu, Chairman of the Managing Board, CEO and President Member of Global Strategic Committee, Member of Group Management Reporting Committee and Member of Steering Committee | ||
| Takashi Ono, Executive Officer | ||
| Kaoru Asano, Sr. Executive Officer, Member of the Managing Board and Director | ||
| Kensuke Lizuka, Sr Div | ||
| Hiroshi Kanda, Executive Officer | ||
| Mitsuhisa Kanagawa, Executive Officer | ||
| Iwane Matsui, Executive Officer | ||
| Mamoru Kubota, Executive Officer |
Sysmex Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Sysmex a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0955 | |||
| Profit Margin | 0.11 % | |||
| Operating Margin | 0.18 % | |||
| Current Valuation | 13.3 B | |||
| Shares Outstanding | 209.24 M | |||
| Shares Owned By Insiders | 26.79 % | |||
| Shares Owned By Institutions | 31.37 % | |||
| Price To Earning | 44.34 X | |||
| Price To Book | 4.74 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Sysmex Pink Sheet
Sysmex financial ratios help investors to determine whether Sysmex Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sysmex with respect to the benefits of owning Sysmex security.